Hudson Bay Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.1M	Sell	190,000 -120,950	-39%	-$2.61M	0.01%	425
2025 Q1	$5.16M	Buy	310,950 +45,950	+17%	+$763K	0.02%	346
2024 Q4	$4.86M	Sell	265,000 -110,000	-29%	-$2.02M	0.02%	366
2024 Q3	$5.77M	Sell	375,000 -12,500	-3%	-$192K	0.02%	281
2024 Q2	$6.3M	Buy	387,500 +162,500	+72%	+$2.64M	0.03%	266
2024 Q1	$4.16M	Buy	+225,000	New	+$4.16M	0.02%	285
2023 Q2	–	Sell	-50,000	Closed	-$941K	–	763
2023 Q1	$941K	Sell	50,000 -150,000	-75%	-$2.82M	0.01%	554
2022 Q4	$3.18M	Buy	200,000 +25,000	+14%	+$398K	0.03%	460
2022 Q3	$2.86M	Sell	175,000 -105,000	-38%	-$1.72M	0.03%	599
2022 Q2	$3.95M	Buy	280,000 +260,000	+1,300%	+$3.66M	0.03%	505
2022 Q1	$484K	Sell	20,000 -25,000	-56%	-$605K	0.01%	858
2021 Q4	$1.05M	Sell	45,000 -181,000	-80%	-$4.22M	0.01%	764
2021 Q3	$3.75M	Buy	226,000 +166,000	+277%	+$2.76M	0.05%	439
2021 Q2	$1.46M	Buy	60,000 +30,000	+100%	+$732K	0.02%	652
2021 Q1	$774K	Buy	+30,000	New	+$774K	0.01%	693
2020 Q4	–	Sell	-30,000	Closed	-$1.24M	–	566
2020 Q3	$1.24M	Buy	+30,000	New	+$1.24M	0.02%	385
2020 Q2	–	Hold	0	–	–	–	475
2019 Q4	–	Hold	0	–	–	–	399
2019 Q3	–	Sell	-15,000	Closed	-$401K	–	368
2019 Q2	$401K	Hold	15,000	–	–	0.01%	321
2019 Q1	$403K	Hold	15,000	–	–	0.01%	373
2018 Q4	$243K	Sell	15,000 -25,000	-63%	-$405K	﹤0.01%	414
2018 Q3	$830K	Hold	40,000	–	–	0.01%	367
2018 Q2	$611K	Buy	+40,000	New	+$611K	0.01%	396
2017 Q2	–	Sell	-80,000	Closed	-$2.75M	–	338
2017 Q1	$2.75M	Buy	+80,000	New	+$2.75M	0.04%	168